Skip to content

Risk-free rate at other companies

Utah Medical Products logo
Utah Medical ProductsUTMD
3.8%-0.5pp
Ashland logo
AshlandASH
4.3%-0.3pp
Boston Beer logo
Boston BeerSAM
3.4%-0.9pp
Bicara Therapeutics logo
Bicara TherapeuticsBCAX
3.8%
Richardson Electronics logo
Richardson ElectronicsRELL
4.2%+0.2pp
AIR
Air TAIRT
4.1%+3.2pp

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate.

The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's risk-free rate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's risk-free rate?
Utah Medical Products (UTMD) reported risk-free rate of 3.8% in Q4 2025.
What does risk-free rate mean?
The risk-free interest rate used in option pricing models to discount the expected future value of equity awards to their present value. This rate is typically based on the yield of government bonds with a maturity matching the expected term of the awards. It serves as a standard financial assumption for valuing employee compensation.